LYNPARZA
Identification of Lynparza
No description |
Google image searchProduct monograph
Active ingredient
olaparib, 100 MG
DIN: 02475200
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: ASTRAZENECA CANADA INC
Date: 23-MAY-2018
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XK — Poly (ADP-ribose) polymerase (PARP) inhibitors (ATC, ATC/DDD)
- L01XK01 — OLAPARIB (ATC/DDD)
External Links for Lynparza
Search on Google
Astrazeneca Canada Inc
Go to AstraZeneca website to see drug product details. Sometimes you can find lynparza photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.